sever
acut
respiratori
syndrom
sar
acut
newli
emerg
infecti
respiratori
ill
etiolog
agent
sar
name
sarsassoci
coronaviru
sarscov
detect
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
studi
set
nest
primer
cover
sarscov
genom
screen
show
suffici
sensit
detect
sarscov
rna
isol
viru
cultur
vero
cell
optim
reaction
condit
nest
primer
set
seven
set
nest
primer
chosen
compar
revers
transcrib
effici
specif
random
primer
use
combin
rt
first
round
pcr
onestep
rtpcr
base
sensit
simplic
result
primer
set
chosen
candid
primer
set
clinic
diagnos
specifi
amplicon
minim
fals
posit
result
taqman
rtnest
pcr
system
nest
primer
set
develop
investig
test
panel
whole
blood
obtain
sar
patient
control
person
specif
sensit
taqman
rtnest
pcr
system
found
respect
suggest
method
promis
one
diagnos
sar
earli
stage
outbreak
newli
emerg
infecti
diseas
refer
sever
acut
respiratori
syndrom
sar
first
identifi
guangdong
provinc
china
novemb
infect
mani
individu
result
death
around
world
juli
http
wwwwhointcsrsarsen
etiolog
agent
sar
identifi
new
coronaviru
name
sarsassoci
coronaviru
sarscov
ksiazek
et
al
drosten
et
al
sarscov
envelop
positivestrand
rna
viru
genom
strain
sarscov
sequenc
marra
et
al
rota
et
al
ruan
et
al
qin
et
al
size
genom
kb
longest
rna
posit
strand
viru
date
base
genet
analysi
genom
sequenc
sarscov
classifi
distinct
group
previous
known
coronaviru
symptom
sar
resembl
form
atyp
pneumonia
usual
caus
mycoplasma
chlamydia
speci
other
absenc
effect
drug
vaccin
sar
rapid
identif
diseas
import
control
spread
present
viru
isol
cell
cultur
elisa
ifa
revers
transcriptionpolymeras
chain
reaction
rtpcr
major
method
diagnos
sar
elisa
ifa
method
depend
detect
igg
andor
igm
sarscov
viru
emerg
blood
later
phase
infect
drosten
et
al
critic
need
test
detect
sar
earli
stage
ill
day
sinc
person
infect
sarscov
infect
larg
number
individu
easili
rosl
rosl
detect
viral
rna
rtpcr
assay
wide
use
approach
earli
detect
pathogen
poon
et
al
base
genom
sequenc
access
number
set
nest
primer
cover
sarscov
synthes
studi
methodolog
select
nest
primer
promis
primer
clinic
purpos
taqman
rtnest
pcr
system
use
nest
primer
set
describ
system
evalu
test
panel
primer
design
genom
strain
sarscov
target
set
primer
design
softwar
freeli
avail
internet
http
wwwbasicnorthwesternedubio
size
outer
amplicon
inner
amplicon
bp
respect
anneal
temperatur
restrict
rang
c
primer
sequenc
summar
tabl
primer
synthes
dna
biotechnolog
compani
shanghai
fluoregen
probe
nest
primer
set
famaag
gtg
aca
ctc
gct
gat
gct
provid
sangon
biotecholog
compani
shanghai
fam
repres
fluoresc
report
tamra
quencher
link
last
nucleotid
g
rna
virus
cultur
vero
cell
extract
qiaamp
viral
rna
mini
kit
qiagen
whole
blood
sampl
patient
diagnos
clinic
sar
use
panel
patient
femalemal
age
high
fever
day
highest
temperatur
regard
day
meantim
whole
blood
sampl
nine
control
person
also
includ
test
panel
qiaamp
rna
blood
mini
kit
qiagen
use
prepar
whole
blood
sampl
test
panel
accord
manufactur
instruct
rna
elut
final
volum
l
elut
buffer
procedur
perform
biosafeti
level
laboratori
revers
transcript
reaction
carri
separ
random
primer
specif
primer
reaction
mixtur
includ
ng
random
primer
l
specif
primer
l
total
rna
l
dntp
mm
mixtur
heat
c
min
place
immedi
ice
follow
reagent
ad
mixtur
l
first
strandsynthesi
buffer
promega
l
dtt
promega
l
rnase
inhittor
ul
promega
l
superscript
ii
rnase
hrt
ul
invitrogen
rt
reaction
carri
c
min
follow
incub
c
min
final
inactiv
enzym
c
min
first
round
pcr
carri
l
volum
contain
l
rt
product
primer
unit
taq
dna
polymeras
promega
mm
dntp
mm
trishcl
ph
mm
kcl
mm
mgcl
thermocycl
perform
thermocyl
mjresearch
mjresearch
inc
initi
denatur
min
c
follow
cycl
c
optim
tm
c
final
extens
reaction
perform
min
c
complet
pcr
reaction
second
round
pcr
undertaken
icycl
biorad
detect
pcr
product
sybr
green
taqman
probe
second
round
reaction
use
mixtur
reaction
volum
second
round
pcr
also
l
contain
l
product
first
round
pcr
reaction
primer
unit
taq
dna
polymeras
promega
mm
dntp
mm
trishcl
ph
mm
kcl
mm
mgcl
l
sybr
green
l
taqman
probe
use
taqman
probe
mixtur
thermocycl
carri
initi
denatur
min
c
follow
cycl
c
c
min
detect
sybr
green
thermocycl
carri
initi
denatur
min
c
follow
cycl
c
optim
tm
c
melt
curv
complet
c
increas
c
per
cycl
investig
amplicon
set
nest
primer
use
studi
distribut
unevenli
sar
genom
span
known
gene
two
predict
gene
identifi
sarscov
genom
fig
compar
sensit
set
nest
primer
serial
dilut
genom
cdna
revers
transcrib
random
primer
use
templat
carri
nest
pcr
initi
concentr
total
rna
viru
vero
cell
ngl
correspond
molecul
sarscov
per
microlit
nest
primer
set
could
detect
dilut
rna
correspond
copi
sar
genom
per
microlit
no
nest
primer
set
sever
copi
sar
genom
could
detect
although
sporad
signal
occur
dilut
templat
repres
random
unreli
result
fig
compar
revers
transcrib
effici
random
primer
versu
specif
primer
seven
set
nest
primer
cover
known
gene
chosen
test
dilut
genom
rna
seri
revers
transcript
carri
separ
random
primer
specif
primer
amplif
outer
primer
cdna
perform
product
monitor
sybr
green
bind
doubl
dna
result
show
three
seven
set
nest
primer
better
effici
templat
revers
transcrib
specif
primer
three
set
primer
show
revers
transcript
random
primer
higher
effici
specif
primer
worthi
note
four
set
nest
primer
locat
terminu
genom
higher
effici
transcrib
random
primer
contrast
three
set
primer
target
initi
region
genom
higher
effici
transcrib
specif
primer
outer
revers
primer
pair
sensit
cdna
revers
transcrib
specif
primer
meanwhil
primer
attain
sensit
cdna
revers
transcrib
random
primer
fig
nest
primer
set
found
promis
primer
clinic
diagnosi
taqman
probe
target
intern
region
inner
amplicon
design
minim
fals
posit
result
taqman
probe
nest
primer
pair
togeth
constitut
taqman
rtnest
pcr
system
test
specif
taqman
rtnest
pcr
system
panel
consist
set
rna
sar
patient
whole
blood
set
rna
control
person
whole
blood
use
rna
sampl
revers
transcrib
outer
revers
primer
first
round
pcr
second
round
pcr
perform
monitor
real
time
pcr
none
control
sampl
produc
signal
wherea
sampl
sar
patient
produc
detect
signal
result
show
sensit
lower
margin
bar
show
level
sensit
outer
primer
no
higher
revers
transcript
effici
transcrib
specif
primer
wherea
primer
no
higher
revers
transcript
effici
transcrib
random
primer
valu
vertic
axi
repres
dilut
concentr
rna
compar
initi
rna
ngl
specif
taqman
rtnest
pcr
system
respect
tabl
strike
featur
sarsassoci
viru
spike
spherelik
virion
clearli
observ
electron
microscop
basi
name
coronavira
spike
protein
togeth
e
protein
constitut
compon
surfac
coronavirus
replicas
r
protein
occur
limit
amount
includ
defin
uniqu
nonstructur
protein
respons
rna
replic
accord
northern
blot
subgenom
region
e
transcrib
larger
quantiti
dilut
rna
templat
sensit
primer
target
e
n
protein
higher
primer
target
r
protein
suggest
sensit
detect
determin
mostli
quantiti
transcript
nucleic
acid
amplif
techniqu
combin
revers
transcript
polymeras
chain
reaction
appli
detect
sar
primer
primari
compon
necessari
develop
rtnest
pcr
size
outer
amplicon
set
rang
bp
usual
suffici
long
design
inner
primer
space
interv
bp
compar
longer
pcr
product
rang
flexibl
enabl
mani
assay
produc
success
primer
revers
transcript
random
primer
specif
primer
differ
effect
accord
sensit
simplic
test
result
primer
appear
promis
primer
set
clinic
diagnosi
use
simplifi
detect
process
combin
rt
first
round
pcr
reaction
onestep
rtpcr
reaction
nest
pcr
detect
low
amount
viru
necessari
import
adopt
strict
criteria
confirm
posit
result
product
confirm
sarscov
number
method
includ
taqman
dna
chip
pcrelisa
sequenc
studi
taqman
probe
appli
confirm
pcr
product
taqman
system
develop
abi
employ
fluoregen
probebas
exonucleas
technolog
enabl
amplif
detect
carri
simultan
elimin
need
postpcr
analysi
heid
et
al
fortin
et
al
use
fluoresc
probe
real
time
pcr
provid
addit
level
assay
specif
although
fluoresc
increas
direct
proport
amount
specif
amplicon
taqman
probe
use
specifi
product
studi
fluoresc
increas
nonlinearli
second
round
amplif
compar
origin
viru
rna
concentr
confirm
posit
amplicon
pcr
procedur
includ
appropri
neg
posit
control
run
includ
neg
posit
control
extract
procedur
pcr
run
sarscov
detect
multipl
specimen
includ
extract
lung
sputum
upper
respiratori
tract
swab
aspir
stool
blood
sampl
via
pcr
viral
isol
drosten
et
al
poon
et
al
high
concentr
viral
rna
million
molecul
per
millilit
detect
sputum
viral
rna
also
detect
extrem
low
concentr
plasma
acut
ill
phase
fece
late
convalesc
phase
suggest
sarscov
may
shed
fece
prolong
period
time
compar
sputum
fece
blood
use
frequent
clinic
practic
rel
easi
obtain
studi
whole
blood
therefor
use
test
sampl
order
develop
clinic
use
detect
method
earli
stage
infect
accord
protocol
develop
studi
sensit
specif
taqman
rtnest
pcr
system
respect
neg
result
exclud
exist
sarscov
test
sampl
may
attribut
low
amount
rna
sampl
sensit
rtnest
pcr
test
sar
depend
specimen
time
test
cours
ill
rapid
diagnosi
offer
consider
benefit
posit
case
quickli
identifi
also
equal
inform
rapid
neg
result
obtain
optim
patient
manag
appropri
therapi
taqman
rtnest
pcr
system
describ
provid
rapid
sensit
cost
effect
approach
diagnosi
sarscov
infect
